BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26939774)

  • 1. The current perspective of low-grade myelodysplastic syndrome in children.
    Hasegawa D
    Int J Hematol; 2016 Apr; 103(4):360-4. PubMed ID: 26939774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
    Frietsch JJ; Dornaus S; Neumann T; Scholl S; Schmidt V; Kunert C; Sayer HG; Hochhaus A; La Rosée P
    Eur J Haematol; 2014 Sep; 93(3):247-59. PubMed ID: 24635656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood Myelodysplastic Syndrome.
    Chisholm KM; Bohling SD
    Clin Lab Med; 2023 Dec; 43(4):639-655. PubMed ID: 37865508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric carcinoma subsequent to myelodysplastic syndrome with t (1; 19) chromosome translocation: A rare case report and its potential mechanisms.
    Yu W; Chen G; Sun Y; Gao S; Li W; Cui J; Sun J
    Medicine (Baltimore); 2018 Jul; 97(30):e11535. PubMed ID: 30045276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes.
    Ivy KS; Brent Ferrell P
    Curr Hematol Malig Rep; 2018 Aug; 13(4):244-255. PubMed ID: 29934935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Deciphering Hypoplastic Myelodysplastic Syndrome and Aplastic Anemia via In-Depth Analysis of Lymphocyte Subsets].
    Wu HF; Wang SC; Huang JB; Huo JL; Shao YQ; Ren X; Li XX; Wang M; Nie N; Zhang J; Jin P; Ge ML; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1125-1132. PubMed ID: 37551487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic and myeloproliferative disorders of childhood.
    Hasle H
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):598-604. PubMed ID: 27913534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria.
    Luzzatto L
    F1000Res; 2016; 5():. PubMed ID: 26962442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS.
    De La Serna J; Sanz J; Bermúdez A; Cabrero M; Serrano D; Vallejo C; Gómez V; Moraleda JM; Perez SG; Caballero MD; Conde E; Lahuerta JJ; Sanz G
    Bone Marrow Transplant; 2016 Jul; 51(7):961-6. PubMed ID: 26950372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes in children.
    Galaverna F; Ruggeri A; Locatelli F
    Curr Opin Oncol; 2018 Nov; 30(6):402-408. PubMed ID: 30222640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of childhood myelodysplastic syndrome].
    Hasegawa D
    Rinsho Ketsueki; 2021; 62(4):229-238. PubMed ID: 33967145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Approaches to Myelodysplastic Syndrome Treatment.
    Bazinet A; Bravo GM
    Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we manage adults with myelodysplastic syndrome.
    Fenaux P; Platzbecker U; Ades L
    Br J Haematol; 2020 Jun; 189(6):1016-1027. PubMed ID: 31568568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current approach to the diagnosis of myelodysplastic syndromes
    Weinberg OK; Hasserjian RP
    Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of rare pediatric myeloid neoplasia-Quo vadis?
    Niemeyer CM; Rudelius M; Shimamura A; Flotho C; Hasle H; Stieglitz E; Strahm B; Godley LA; Weinberg OK; Orazi A; Calvo KR
    Leukemia; 2022 Dec; 36(12):2947-2948. PubMed ID: 36271151
    [No Abstract]   [Full Text] [Related]  

  • 18. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
    Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
    Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center.
    Gao J; Hu Y; Gao L; Xiao P; Lu J; Hu S
    BMC Pediatr; 2022 May; 22(1):312. PubMed ID: 35624441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histopathology of bone marrow failure in children.
    Iwafuchi H
    J Clin Exp Hematop; 2018; 58(2):68-86. PubMed ID: 29998978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.